Amtrax (India) Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.33 Cr
- Satisfied Charges ₹ 13.34 Cr
- Revenue Growth 5.23%
- Profit Growth -250.62%
- Ebitda 41.10%
- Net Worth -9.97%
- Total Assets 7.86%
About Amtrax (India) Life Sciences
Amtrax (India) Life Sciences Private Limited (AILSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 April 2012 and has a history of 12 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹25.33 Cr. The company has closed loans amounting to ₹13.34 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arvind Patil, Pravin Shyam, and Kunjeshkumar Shah serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74120MH2012PTC229327
-
Company No.
229327
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Apr 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Amtrax (India) Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunjeshkumar Shah
|
Director | 12-Feb-2015 | Current |
|
Arvind Patil
|
Director | 09-Apr-2012 | Current |
|
Pravin Shyam
|
Director | 09-Apr-2012 | Current |
Financial Performance of Amtrax (India) Life Sciences.
Amtrax (India) Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.23% increase. The company also saw a substantial fall in profitability, with a 250.62% decrease in profit. The company's net worth dipped by a decrease of 9.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amtrax (India) Life Sciences?
In 2023, Amtrax (India) Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹25.33 Cr
₹13.34 Cr
Charges Breakdown by Lending Institutions
- Others : 25.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jul 2024 | Others | ₹3.18 M | Open |
| 04 May 2024 | Others | ₹1.00 Cr | Open |
| 22 Jul 2022 | Others | ₹1.46 M | Open |
| 13 Nov 2020 | Others | ₹23.87 Cr | Open |
| 28 Feb 2022 | Others | ₹1.00 Cr | Satisfied |
How Many Employees Work at Amtrax (India) Life Sciences?
Unlock and access historical data on people associated with Amtrax (India) Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amtrax (India) Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amtrax (India) Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
